Table 2 |
|
|
Demographics and clinical features of RA patients |
|
|
Parameter |
Value |
|
|
|
|
Age, mean ± SD years |
48 ± 16.5 |
|
Sex, male/female |
8/33 |
|
Duration of symptoms, mean ± SD months |
58.28 ± 51.84 |
|
RF positive, % |
84.85% |
|
RF titer, median units(range) |
117.4(20-1060) |
|
ESR, mean ± SD mm/hours |
67.94 ± 21.19 |
|
CCP titer, median units(range) |
74.5(15-800) |
|
Stiffness, median minutes(range) |
76.67 ± 91.31 |
|
DAS28 (ESR) score, mean ± SD |
6.35 ± 1.45 |
|
|
|
|
CCP, cyclic citrullinated peptide antibody; DAS28, Disease Activity Score using 28 joint counts; ESR, erythrocyte sedimentation rate; RA, rheumatoid arthritis; RF, rheumatoid factor; SD, standard deviation. |
|
|
Li et al. Arthritis Research & Therapy 2010 12:R81 doi:10.1186/ar3006 |
|